Cargando…
Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
BACKGROUND: The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to pla...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571496/ https://www.ncbi.nlm.nih.gov/pubmed/28837004 http://dx.doi.org/10.1186/s13643-017-0565-9 |
_version_ | 1783259350720053248 |
---|---|
author | Dutton, Heidi Doyle, Mary-Anne Buchan, C. Arianne Mohammad, Shuhiba Adamo, Kristi B. Shorr, Risa Fergusson, Dean A. |
author_facet | Dutton, Heidi Doyle, Mary-Anne Buchan, C. Arianne Mohammad, Shuhiba Adamo, Kristi B. Shorr, Risa Fergusson, Dean A. |
author_sort | Dutton, Heidi |
collection | PubMed |
description | BACKGROUND: The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to play a causative role in increasing body weight. There is evidence that antibiotics can modify the composition and diversity of the gut microbiome and that this may contribute to body weight changes. The primary objective of the proposed systematic review is to evaluate and synthesize the existing evidence evaluating the possible association between antibiotic use, weight gain, and obesity. METHODS: A comprehensive search of the MEDLINE and EMBASE databases will be performed. Both randomized and non-randomized studies (excluding case reports) in neonates, children, adults, and pregnant women will be included. The exposure of interest is antibiotics of any type, duration, and route given for any indication. All included studies must have a comparator group. The primary outcomes are the development of overweight and obesity. Secondary outcomes are percent weight-change from baseline and change in body mass index or waist circumference. Additional secondary outcomes in pregnant women are gestational weight gain, postpartum weight retention, offspring birth weight, childhood weight, and obesity. Risk of bias of included trials will be performed. Two reviewers will screen and perform data extraction independently. DISCUSSION: This systematic review will summarize the existing evidence evaluating the association between antibiotic use, weight gain, and obesity and facilitate the identification of important gaps and uncertainties in the literature. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017069177 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0565-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5571496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55714962017-08-29 Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review Dutton, Heidi Doyle, Mary-Anne Buchan, C. Arianne Mohammad, Shuhiba Adamo, Kristi B. Shorr, Risa Fergusson, Dean A. Syst Rev Protocol BACKGROUND: The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to play a causative role in increasing body weight. There is evidence that antibiotics can modify the composition and diversity of the gut microbiome and that this may contribute to body weight changes. The primary objective of the proposed systematic review is to evaluate and synthesize the existing evidence evaluating the possible association between antibiotic use, weight gain, and obesity. METHODS: A comprehensive search of the MEDLINE and EMBASE databases will be performed. Both randomized and non-randomized studies (excluding case reports) in neonates, children, adults, and pregnant women will be included. The exposure of interest is antibiotics of any type, duration, and route given for any indication. All included studies must have a comparator group. The primary outcomes are the development of overweight and obesity. Secondary outcomes are percent weight-change from baseline and change in body mass index or waist circumference. Additional secondary outcomes in pregnant women are gestational weight gain, postpartum weight retention, offspring birth weight, childhood weight, and obesity. Risk of bias of included trials will be performed. Two reviewers will screen and perform data extraction independently. DISCUSSION: This systematic review will summarize the existing evidence evaluating the association between antibiotic use, weight gain, and obesity and facilitate the identification of important gaps and uncertainties in the literature. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017069177 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0565-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-24 /pmc/articles/PMC5571496/ /pubmed/28837004 http://dx.doi.org/10.1186/s13643-017-0565-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Protocol Dutton, Heidi Doyle, Mary-Anne Buchan, C. Arianne Mohammad, Shuhiba Adamo, Kristi B. Shorr, Risa Fergusson, Dean A. Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
title | Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
title_full | Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
title_fullStr | Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
title_full_unstemmed | Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
title_short | Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
title_sort | antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571496/ https://www.ncbi.nlm.nih.gov/pubmed/28837004 http://dx.doi.org/10.1186/s13643-017-0565-9 |
work_keys_str_mv | AT duttonheidi antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview AT doylemaryanne antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview AT buchancarianne antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview AT mohammadshuhiba antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview AT adamokristib antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview AT shorrrisa antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview AT fergussondeana antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview |